SEC Comment Letter 0000000000-23-006738 to Enfusion, Inc. (ENFN) (CIK 0001868912)
Enfusion, Inc. (ENFN) (CIK 0001868912)
Date: June 23, 2023 · CIK: 0001868912 · Accession: 0000000000-23-006738
AI Filing Summary & Sentiment
File numbers found in text: 001-40949
Letter
United States securities and exchange commission logo June 23, 2023 Bradley Herring Chief Financial Officer Enfusion, Inc. 125 South Clark Street, Suite 750 Chicago, IL 60603 Re:Enfusion, Inc. Form 10-K for the Year Ended December 31, 2022 Filed March 10, 2023 File No. 001-40949 Dear Bradley Herring: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Technology
Show Raw Text
United States securities and exchange commission logo
June 23, 2023
Bradley Herring
Chief Financial Officer
Enfusion, Inc.
125 South Clark Street, Suite 750
Chicago, IL 60603
Re:Enfusion, Inc.
Form 10-K for the Year Ended December 31, 2022
Filed March 10, 2023
File No. 001-40949
Dear Bradley Herring:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Technology